Location: Home
  • search
  • go
  • Feature Articles
  • 5/20/2026Global Pharma and China Biotech Race Into a New Era of High-Stakes Lic...
  • 5/19/2026The China question Is Tearing Biotech Apart (STAT)
  • 5/18/2026China's RWE Evolution: From Pilot to Practice (Simon-Kucher)
  • 5/18/2026Nature Analysis Highlights China's Rise as Global Clinical Trial Hub
  • 5/14/2026Pharma CEOs Missing From Trump's China Delegation
  • 5/14/2026Life Sciences a "Sweet Spot" for U.S.-China Cooperation Ahead of Trump...
  • 5/11/2026China Emerges as Global Hub for siRNA Out-Licensing Deals: PharmaDJ
  • 5/5/2026A Strategic Playbook for Chinese Biotech Cross-Border Deals: Navigatin...
  • 5/1/2026A Biopharmaceutical Superpower: China's Rise, Its Limits, and What Com...
  • 4/29/2026China Partnerships Drive Biopharma Deal Surge to $79B in Q1 2026
  • 4/29/2026From fast follower to originator: How Asia is rewiring biopharma innov...
  • 4/28/2026China Imposes Four-Year Deadline on Conditionally Approved Drugs, Tigh...
  • 4/27/2026China Biopharma Financing Rebounds in March as AI Startups and Mega-De...
  • 4/22/2026China Biopharma Deal Activity Slows in Q1 2026, but Upfront Payments S...
  • 4/22/2026China's Push to Elevate Private Health Insurance Faces Structural Hurd...
  • 4/21/2026Chinese Biotech Commands One-Third of Global Pharma Deal Value in 16-M...
  • 4/16/2026China Deepens Opening of Biotech and Healthcare Sectors to Attract Glo...
  • 4/16/20262026 Biotech Playbook: Hong Kong at the Centre of China's Globalisatio...
  • 4/15/2026China's Pharma Innovators Pursue a Range of Deal Structures to Support...
  • 4/15/2026China Private Biotech Funding Slows in Deal Count but Reaches US$2 Bil...
  • 4/14/2026PhRMA Warns U.S. Drug Pricing Policies Could Accelerate China's Rise i...
  • 4/13/2026How Big Pharma's China Trials Are Escaping Scrutiny (The Wire China)
  • 4/13/2026China Outbound Biopharma Licensing Surges as Global Demand for Innovat...
  • 4/9/2026China Backs Independent Pricing for Innovative Drugs in Landmark State...
  • 4/9/2026China's Innovative Drug Out-Licensing Surge Tops CNY 400B in Q1 as Gl...
  • 4/8/2026Global Drugmakers Brace for Another Tough China Year as Beijing Intens...
  • 4/7/2026Pharma Bets Big on Chinese Drugmakers (The Wire China)
  • 4/7/2026China NMPA Clears 17 Novel Drugs in First Quarter, Highlighting Sustai...
  • 4/3/2026China's $13B Pharma Boom Drives Growth But Faces Hurdles in US and EU ...
  • 4/1/2026Biotech VCs Move Upstream in China as Competition for Innovation Inten...
  • Page:1/6 Total number of articles:170: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group